Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025

About this update from Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A